The CHIPTS mission aims to leverage world class science to combat HIV globally, in partnership with communities impacted by the pandemic. We prioritize our research efforts on HIV identification, prevention, and treatment services. To achieve our mission, we collaborate with world-renowned investigators from UCLA, Charles R. Drew University of Medicine and Science (Drew), RAND Corporation (RAND), Friends Research Institute (Friends) and other research and community partners in the U.S. and abroad. The complex challenges of a different world demand a refining of the focus of CHIPTS. To respond to these emerging scientific issues, we will: 1) broaden our agenda to include a domestic and an international research agenda;2) systematically study pioneering intervention strategies, especially those that integrate emerging biomedical technologies, novel delivery vehicles and direct consumer involvement to adapt and adopt effective programs;and 3) determine the benefits and costs of policies aimed at reducing HIV at individual, family, community, national, and international levels. CHIPTS agenda will be implemented through six cores: Administrative, Development, Methods, Policy, Intervention and International. Two of our previous six Cores will change. We will establish an International Core, in this competing continuation application, to provide a mechanism whereby CHIPTS scientists can link our domestic and international projects for their mutual benefit. The expertise of the former Treatment Services Core will become part of the Intervention Core. Over the next five years, the CHIPTS Intervention Core will increase the reach of behavioral interventions for high-risk groups and build upon existing behavioral and biomedical collaborator efforts to develop and evaluate new biomedical approaches to prevention. The mission of CHIPTS is advanced through specific science, networking and capacity building goals and key scientific themes. As a Center, CHIPTS hopes to leverage human capital and financial support to make a significant impact by bringing insights from behavioral science to the implementation of biomedical technologies for HIV prevention, to adapt and adopt efficacious interventions and to apply digital technology to HIV prevention efforts. CHIPTS is both a source and summit of resources for our local and international partners and makes a critical and sustainable impact in HIV identification, prevention and treatment studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH058107-14
Application #
7776922
Study Section
Special Emphasis Panel (ZMH1-ERB-N (11))
Program Officer
Brouwers, Pim
Project Start
1997-09-30
Project End
2012-01-31
Budget Start
2010-02-01
Budget End
2011-01-31
Support Year
14
Fiscal Year
2010
Total Cost
$2,151,981
Indirect Cost
Name
University of California Los Angeles
Department
Type
Other Domestic Higher Education
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Reback, Cathy J; Clark, Kirsty; Holloway, Ian W et al. (2018) Health Disparities, Risk Behaviors and Healthcare Utilization Among Transgender Women in Los Angeles County: A Comparison from 1998-1999 to 2015-2016. AIDS Behav 22:2524-2533
Clark, Kirsty; Fletcher, Jesse B; Holloway, Ian W et al. (2018) Structural Inequities and Social Networks Impact Hormone Use and Misuse Among Transgender Women in Los Angeles County. Arch Sex Behav 47:953-962
Fulcher, Jennifer A; Shoptaw, Steven; Makgoeng, Solomon B et al. (2018) Brief Report: Recent Methamphetamine Use Is Associated With Increased Rectal Mucosal Inflammatory Cytokines, Regardless of HIV-1 Serostatus. J Acquir Immune Defic Syndr 78:119-123
Laeyendecker, Oliver; Konikoff, Jacob; Morrison, Douglas E et al. (2018) Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. J Int AIDS Soc 21:
Reback, Cathy J; Fletcher, Jesse B; Swendeman, Dallas (2018) Associations between Sociodemographic Characteristics and Sexual Risk Behaviors among Methamphetamine-using Men who Have Sex with Men. Subst Use Misuse 53:1826-1833
Fletcher, Jesse B; Swendeman, Dallas; Reback, Cathy J (2018) Associations Between Major Depressive Episode, Methamphetamine Use Disorder Severity, and Engagement in Sexual Risk-Taking Among Methamphetamine-Using Men Who Have Sex with Men. AIDS Behav 22:1461-1466
Eshleman, Susan H; Piwowar-Manning, Estelle; Sivay, Mariya V et al. (2018) Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection. J Clin Virol 99-100:67-70
Beymer, Matthew R; Gildner, Jennifer L; Holloway, Ian W et al. (2018) Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in California. LGBT Health 5:341-349
Holloway, Ian W; Wu, Elizabeth S C; Gildner, Jennifer et al. (2018) Quadrivalent Meningococcal Vaccine Uptake Among Men Who Have Sex With Men During a Meningococcal Outbreak in Los Angeles County, California, 2016-2017. Public Health Rep 133:559-569
Lin, Chunqing; Tuan, Nguyen Anh; Li, Li (2018) Commune Health Workers' Methadone Maintenance Treatment (MMT) Knowledge and Perceived Difficulties Providing Decentralized MMT Services in Vietnam. Subst Use Misuse 53:194-199

Showing the most recent 10 out of 715 publications